Diabetes · Syracuse, NY
Diabetes studies in Syracuse, NY
3 recruiting studies have a site in Syracuse.
3 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Syracuse, NY + 39 other US sites
- Eligibility basics
- Ages 10–17
- Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Insulet Corporation
- Location
- Syracuse, NY + 25 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
Effects of HIIT vs. TRE on Type 2 Diabetes Risk
Syracuse University
- Location
- Syracuse, NY
- Eligibility basics
- Ages 14–30
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.